Scholarlink

<p>In contemporary antibacterial treatment, the inability to effectively penetrate biofilm structures, coupled with the rising prevalence of antimicrobial resistance, significantly compromise the clinical efficacy of antibiotic-based therapies. Herein, we propose a hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-propelled <i>Janus</i> nanomotor designed to co-deliver vancomycin (Van) and silver ions (Ag⁺), thereby enabling synergistic therapy against refractory biofilm infections. The nanomotor is fabricated by self-assembling Van with FDA-approved biocompatible poloxamer 188 (F68) and tannic acid (TA) to create a Van-loaded nanocarrier, with silver nanoparticles (AgNPs) subsequently deposited on one side to generate the final structure (F68@TA/Van@Ag). Within the acidic biofilm microenvironment, oxygen generated through the catalytic decomposition of H<sub>2</sub>O<sub>2</sub> by asymmetrical AgNPs facilitates autonomous movement, allowing efficient biofilm penetration and achieving a 3.9-fold increase in the effective concentration of Van. Concurrently, Ag⁺ released during decomposition induces oxidative stress within bacterial cells, disrupts membrane integrity, and interferes with DNA replication; these actions collectively enhance biofilm eradication in conjunction with Van treatment. Notably, F68@TA/Van@Ag reprograms macrophages toward pro-inflammatory polarization, thus activating robust antibacterial innate immune responses. Overall, our H<sub>2</sub>O<sub>2</sub>-propelled <i>Janus</i> nanomotor F68@TA/Van@Ag demonstrates remarkable antibiofilm properties and immunomodulatory effects while maintaining biocompatibility, offering a promising therapeutic strategy for addressing refractory biofilm infections — particularly those drug-resistant biofilm infections.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

H2O2-propelled Janus nanomotor for synergistic treatment of drug-resistant biofilm infections

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月16日

查看全文
  • Daifeng Li,
  • Lurui Yang,
  • Liuliang He,
  • Bowen Liu,
  • Yuhui Yuan,
  • Zhichao Wang,
  • Jinjin Shi,
  • Yi Zhang

摘要

In contemporary antibacterial treatment, the inability to effectively penetrate biofilm structures, coupled with the rising prevalence of antimicrobial resistance, significantly compromise the clinical efficacy of antibiotic-based therapies. Herein, we propose a hydrogen peroxide (H2O2)-propelled Janus nanomotor designed to co-deliver vancomycin (Van) and silver ions (Ag⁺), thereby enabling synergistic therapy against refractory biofilm infections. The nanomotor is fabricated by self-assembling Van with FDA-approved biocompatible poloxamer 188 (F68) and tannic acid (TA) to create a Van-loaded nanocarrier, with silver nanoparticles (AgNPs) subsequently deposited on one side to generate the final structure (F68@TA/Van@Ag). Within the acidic biofilm microenvironment, oxygen generated through the catalytic decomposition of H2O2 by asymmetrical AgNPs facilitates autonomous movement, allowing efficient biofilm penetration and achieving a 3.9-fold increase in the effective concentration of Van. Concurrently, Ag⁺ released during decomposition induces oxidative stress within bacterial cells, disrupts membrane integrity, and interferes with DNA replication; these actions collectively enhance biofilm eradication in conjunction with Van treatment. Notably, F68@TA/Van@Ag reprograms macrophages toward pro-inflammatory polarization, thus activating robust antibacterial innate immune responses. Overall, our H2O2-propelled Janus nanomotor F68@TA/Van@Ag demonstrates remarkable antibiofilm properties and immunomodulatory effects while maintaining biocompatibility, offering a promising therapeutic strategy for addressing refractory biofilm infections — particularly those drug-resistant biofilm infections.

Graphical abstract